Pathophysiology and management of gastroesophageal reflux disease

Minerva Gastroenterologica e Dietologica

Volumn 55, Issue 3, 2009, Pages 289-300

  Rohof, W O A ^a   Hirsch, D P ^a   Boeckxstaens, G E E ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Esophageal sphincter, lower; Gastroesophageal reflux; Hernia, hiatal

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ADX 10059; BACLOFEN; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG;

CLINICAL FEATURE; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HIATUS HERNIA; HISTOPATHOLOGY; HUMAN; INTERVENTION STUDY; IRRITABLE COLON; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; LOWER ESOPHAGUS SPHINCTER PRESSURE; MORBIDITY; NAUSEA; PH MEASUREMENT; REVIEW; SEDATION; SIDE EFFECT; STOMACH EMPTYING; TREATMENT OUTCOME;

GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 75749139774     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Modlin IM et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1383-1.
2. Modlin IM, Hunt RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN et al. Non-erosive reflux disease defining the entity and delineating the management. Digestion 2008;78(Suppl 1):1-5.
3. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastroesophageal reflux disease: a systematic review. Gut 2005;54:710-7.
4. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997;112:1798-810.
5. Bate CM, Griffin SM, Keeling PW, Axon AT, Dronfield MW, Chapman RW et al. Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther 1996;10:547-55.
6. Brasseur JG, Ulerich R, Dai Q, Patel DK, Soliman AM, Miller LS. Pharmacological dissection of the human gastro-oesophageal segment into three sphincteric components. J Physiol 2007;580:961-75.
7. Sadler TW. Langman's medical embryology. 9th ed. Philadelphia: Lippincott Williams and Wilkins; 2002. p. 217-9.
8. Pickering M, Jones JF. The diaphragm: two physiological muscles in one. J Anat 2002;201:305-12.
9. Niedringhaus M, Jackson PG, Evans SR, Verbalis JG, Gillis RA, Sahibzada N. Dorsal motor nucleus of the vagus: a site for evoking simultaneous changes in crural diaphragm activity, lower esophageal sphincter pressure, and fundus tone. Am J Physiol Regul Integr Comp Physiol 2008;294:R121-R31.
10. Mitral RK, Rochester DF, McCallum RW. Electrical and mechanical activity in the human lower esophageal sphincter during diaphragmatic contraction. J Clin Invest 1988;81:1182-9.
11. Mittal RK, Holloway R, Dent J. Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects. Gastroenterology 1995;109:1547-54.
12. Dent J, Dodds WJ, Friedman RH, Sekiguchi T, Hogan WJ, Arndorfer RC et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980;65:256-67.
13. Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982;307:1547-52.
14. Holloway RH, Penagini R, Ireland AC. Criteria for objective definition of transient lower esophageal sphincter relaxation. Am J Physiol 1995;268:G128-G33.
15. Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J. Transient lower esophageal sphincter relaxation. Gastroenterology 1995;109:601-10.
16. Sifrim D, Holloway R. Transient lower esophageal sphincter relaxations: how many or how harmful? Am J Gastroenterol 2001;96:2529-32.
17. Trodgill NJ, Riley SA. Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers. Am J Gastroenterol 2O01;96:2569-74.
18. Page AJ, Blackshaw LA. An in vitro study of the properties of vagal afferent fibres innervating the ferret oesophagus and stomach. J Physiol 1998;512(Pt 3):907-16.
19. Babaei A, Bhargava V, Korsapati H, Zheng WH, Mittal RK. A unique longitudinal muscle contraction pattern associated with transient lower esophageal sphincter relaxation. Gastroenterology 2008;134:1322-31.
20. Hirsch DP, Tytgat GN, Boeckxstaens GE. Transient lower oesophageal sphincter relaxations a pharmacological target for gastro-oesophageal reflux disease? Aliment Pharmacol Ther 2002;16:17-26.
21. Kahrilas PJ, Kim HC, Pandolfino JE. Approaches to the diagnosis and grading of hiatal hernia. Best Pract Res Clin Gastroenterol 2008;22:601-16.
22. Jones MP, Sloan SS, Rabine JC, Ebert CC, Huang CF, Kahrilas PJ. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol 2001;96:1711-7.
23. Sgouros SN, Mpakos D, Rodias M, Vassiliades K, Karakoidas C, Andrikopoulos E et al. Prevalence and axial length of hiatus hernia in patients, with non-erosive reflux disease: a prospective study. J Clin Gastroenterol 2007;41:814-8.
24. Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux. Gastroenterology 2006;130:334-40.
25. Jones MP, Sloan SS, Jovanovic B, Kahrilas PJ. Impaired egress rather than increased access: an important independent predictor of erosive oesophagitis. Neurogastroenterol Motil 2002;14:625-31.
26. Mittal RK, Lange RC, McCallum RW. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia. Gastroenterology 1987;92:130-5.
27. van Herwaarden MA, Samsom M, Smout AJ. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology 2000;119:1439-46.
28. Beaumont H, Boeckxstaens GE. The position of the acid pocket as a major risk factor for acidic reflux in healthy subject and GERD patients. Gut 2009. In press
29. Paterson WG, Kolyn DM. Esophageal shortening induced by short-term intraluminal acid perfusion in opossum: a cause for hiatus hernia? Gastroenterology 1994;107:1736-40.
30. Paterson WG, Miller DV, Dilworth N, Assini JB, Lourenssen S, Blennerhassett MG. Intraluminal acid induces oesophageal shortening via capsaicin-sensitive neurokinin neurons. Gut 2007;56:1347-52.
31. Castell DO, Murray JA, Tutuian R, Orlando RC, Arnold R. Review article: the pathophysiology of gastro-oesophageal reflux disease - esophageal manifestations. Aliment Pharmacol Ther 2004;20(Suppl 9): 14-25.
32. Hamoui N, Lord RV, Hagen JA, Theisen J, DeMeester TR, Crookes PF. Response of the lower esophageal sphincter to gastric distension by carbonated beverages. J Gastrointest Surg 2006;10:870-7.
33. Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Arndorfer RC, Reece A. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 1986;91:897-904.
34. Sarosiek J, McCallum RW. Mechanisms of oesophageal mucosal defence. Baillieres Best Pract Res Clin Gastroenterol 2000;14:701-17.
35. Orr WC, Heading R, Johnson LF, Kryger M. Review article: sleep and its relationship to gastro-oesophageal reflux. Aliment Pharmacol Ther 2004;20(Suppl 9):39-46.
36. Adachi K, Fujishiro H, Katsube T, Yuki M, Ono M, Kawamura A et al. Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis. J Gastroenterol Hepatol 2001;16:1191-6.
37. Fletcher J, Wirz A, Young J, Vallance R, McColl KE. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001;121:775-83.
38. Beaumont H, Boeckxstaens GE. Scintigraphic imaging of the acid pocket: an enlarged pocket with acid coating the distal esophagus in GERD patients with hiatal hernia. Gut 2009 In press.
39. Buckles DC, Sarosiek I, McMillin C, McCallum RW. Delayed gastric emptying in gastroesophageal reflux disease: reassessment with new methods and symptomatic correlations. Am J Med Sci 2004;327:1-4.
40. Bredenoord AJ, Weusten BL, Curvers WL, Timmer R, Smout AJ. Determinants of perception of heartburn and regurgitation. Gut 2006;55:313-8.
41. Emerenziani S, Sifrim D. Gastroesophageal reflux and gastric emptying, revisited. Curr Gastroenterol Rep 2005;7:190-5.
42. + injury in rabbit esophageal epithelium. Am J Physiol 1984;246:G718-G24.
43. Snow JC, Goldstein JL, Schmidt LN, Lisitza P, Layden TJ. Rabbit esophageal cells show regulatory volume decrease: ionic basis and effect of pH. Gastroenterology 1993;105:102-10.
44. Roberts NB. Review article: human pepsins - their multiplicity, function and role in reflux disease. Aliment Pharmacol Ther 2006;24(Suppl 2):2-9.
45. Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995;108:1897-907.
46. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Multivariate analysis of the association of acid and duodeno-gastro-esophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus. Gut 2008;57:1056-64.
47. Oh DS, Hagen JA, Fein M, Bremner CG, Dunst CM, DeMeester SR et al. The impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg 2006;10:787-96.
48. Namiot Z, Sarosiek J, Rourk RM, Hetzel DP, McCallum RW. Human esophageal secretion: mucosal response to luminal acid and pepsin. Gastroenterology 1994;106: 973-81.
49. Orlando RC. Esophageal epithelial defense against acid injury. J Clin Gastroenterol 1991;13 Suppl 2:S1-S5.
50. Orlando RC. Review article: oesophageal mucosal resistance. Aliment Pharmacol Ther 1998;12:191-7.
51. Tobey NA, Koves G, Orlando RC. HCl-induced cell edema in primary cultured rabbit esophageal epithelium. Gastroenterology 1997;112:847-54.
52. Boeckxstaens GE. Review article: the pathophysiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007;26:149-60.
53. Edebo A, Vieth M, Tam W, Bruno M, van Berkel AM, Stolte M et al. Circumferential and axial distribution of esophageal mucosal damage in reflux disease. Dis Esophagus 2007;20:232-8.
54. Malenstein H, Farre R, Sifrim D. Esophageal dilated intercellular spaces (DIS) and non-erosive reflux disease. Am J Gastroenterol 2008;103:1021-8.
55. Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC. Dilated intercellular spaces and shunt permeability in non-erosive acid-damaged esophageal epithelium. Am J Gastroenterol 2004;99:13-22.
56. Farre R, van MH, De VR, Geboes K, Depoortere I, Vanden BP et al. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut 2008;57:1366-74.
57. Farre R, De VR, Geboes K, Verbecke K, Vanden BP, Depoortere I et al. Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces. Gut 2007;56:1191-7.
58. Calabrese C, Bortolotti M, Fabbri A, Areni A, Cenacchi G, Scialpi C et al. Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol 2005;100:537-42.
59. Calabrese C, Fabbri A, Bortolotti M, Cenacchi G, Carlo S, Zahlane D et al. Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux. World J Gastroenterol 2005;11:1876-80.
60. Knowles CH, Aziz Q. Visceral hypersensitivity in non-erosive reflux disease. Gut 2008;57:674-83.
61. Holzer P. Acid-sensitive ion channels in gastrointestinal function. Curr Opin Pharmacol 2003;3:618-25.
62. Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, Anand P. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 2004;16:897-902.
63. Bhat YM, Bielefeldt K. Capsaicin receptor (TRPV1) and non-erosive reflux disease. Eur J Gastroenterol Hepatol 2006;18:263-70.
64. Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 2000;356: 1154-9.
65. Wright CE, Ebrecht M, Mitchell R, Anggiansah A, Weinman J. The effect of psychological stress on symptom severity and perception in patients with gastroesophageal reflux. J Psychosom Res 2005;59:415-24.
66. Velden vd A, de Wit NJ, Quartero AO, Grobbee DE, Numans ME. Maintenance treatment for GERD: residual symptoms are associated with psychological distress. Digestion 2008;77:207-13-
67. Schey R, Dickman R, Parthasarathy S, Quan SF, Wendel C, Merchant J et al. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology 2007;133:1787-95.
68. Fass R, Naliboff BD, Fass SS, Peleg N, Wendel C, Malagon IB et al. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology 2008;134:696-705.
69. Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004;140:518-27.
70. Vakil N. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease? Aliment Pharmacol Ther 2005;22(Suppl 1):64-9.
71. Liu JJ, Saltzman JR. Management of gastroesophageal reflux disease. South Med J 2006;99:735-41.
72. Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and metaanalysis. Gastroenterology 2006;131:390-401.
73. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005;100:190-200.
74. Bredenoord AJ, Weusten BL, Smout AJ. Symptom association analysis in ambulatory gastroesophageal reflux monitoring. Gut 2005;54:1810-7.
75. Zerbib F, Roman S, Ropert A, des Varannes SB, Pouderoux P, Chaput U et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006;101:1956-63.
76. Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: "on" or "off" proton pump inhibitor? Am J Gastroenterol 2008;103:2446-53.
77. Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K et al. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol 1999;94:1782-9.
78. Donnellan C, Sharma N, Preston C, Moayyedi P. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2005;CD003245.
79. Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease where next? Aliment Pharmacol Ther 2005;22:79-94.
80. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and non-acid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001;120:1599-606.
81. Hinder RA, Perdikis G, Klinger PJ, DeVault KR. The surgical option for gastroesophageal reflux disease. Am J Med 1997;103:144S-8S.
82. Bais JE, Bartelsman JF, Bonjer HJ, Cuesta MA, Go PM, Klinkenberg-Knol EC et al. Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet 2000;355:170-4.
83. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001;285:2331-8.
84. Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 2000;118:7-13.
85. Ciccaglione AF, Marzio L. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 2003;52:464-70.
86. Alstermark C, Amin K, Dinn SR, Elebring T, Fjellstrom O, Fitzpatrick K et al. Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors. J Med Chem 2008;51:4315-20.
87. Frisby CL, Mattsson JP, Jensen JM, Lehmann A, Dent J, Blackshaw LA. Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands. Gastroenterology 2005;129:995-1004.
88. Jensen J, Lehmann A, Uvebrant A, Carlsson A, Jerndal G, Nilsson K et al. Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist. Eur J Pharmacol 2005;519:154-7.
89. Hirsch DP, Tytgat GN, Boeckxstaens GE. Is glutamate involved in transient lower esophageal sphincter relaxations? Dig Dis Sci 2002;47:661-6.
90. Keywood C, Wakefield M. A single-blind, placebo-controlled, proof of concept study of the effect of the MGLUR5 negative allosteric modulator, ADX10059, on 24h oesophageal pH and clinical symptoms, in patients with gastroesophageal reflux disease. Neurogastroenterol Motil 2008;20:20.
91. Lindstrom E, Brusberg M, Hughes PA, Martin CM, Brierley SM, Phillis BD et al. Involvement of metabotropic glutamate 5 receptor in visceral pain. Pain 2008;137:295-305.
92. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 2003;52:1397-402.
93. Beaumont H, Boeckxstaens GE. Does the presence of a hiatal hernia affects the efficacy of the reflux inhibitor baclofen during add-on therapy? Am J Gastrienterology 2009. In press.
94. Schwartz MP, Smout AJ. Review article: the endoscopic treatment of gastrooesophageal reflux disease. Aliment Pharmacol Ther 2007;26(Suppl 2):1-6.
95. Corley DA, Katz P, Wo JM, Stefan A, Patti M, Rothstein R et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology 2003;125:668-76.
96. Arts J, Sifrim D, Rutgeerts P, Lerut A, Janssens J, Tack J. Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophagal reflux disease. Dig Dis Sci 2007;52:2170-7.
97. Bonavina L, Saino GI, Bona D, Lipham J, Ganz RA, Dunn D et al. Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastrointest Surg 2008;12:2133-40.